Link to podcast to follow
A continuation of last
week’s article, today’s entry will look at whether human genes (or the process
for extracting those from the genome) can be registered as a patent under UK
law by establishing whether the statutory criteria can be met in such cases.
( For a more detailed
definition of the requirements, see << http://myveryownhell.blogspot.co.uk/2013/04/academic-intelligence-are-genes.html
>> )
Novelty
The product/ process must be ‘new’ and
must NOT form a part of the state of the art available to the public at
the priority date (date of filing application as per s. 5 Patent Act 1977 ‘PA’).
Unfortunately, the answer to the above
is not as simple as it looks and is derived from a field of study that I tend
to avoid at all cost- philosophy.
The question that needs to be answered is whether it is
all possible to ‘discover’ genes that have always been there.
If so, would that forces such as gravity, etc. patentable
as well?
As for actual process of separating a gene from the
genome, it can be argued that the end result is something that does, indeed,
form a part of the state of the art available to the public.
Inventive
Step
Because of technological advancement, scientist have been
able to distinguish between various genes and have, eventually, come up with
techniques and process of separating those genes and cloning those.
It is arguable whether the said technological advancement
can amount to an ‘inventive’ step which is not obvious to skilled but
unimaginative professional.
Capable
of Industrial Application
Human genes can be cloned; however, it still remains a
question of morality. The processes for separating genes from the genome and
cloning those to be used in various sorts of medication are currently used by
some US companies who hold valid US patents to the genes used.
Not
Excluded by PA
Under s. 1 (2) PA, a
discovery, scientific theory or mathematical method CANNOT be patented.
Thus, even if
genes WERE to be viewed as scientific discoveries, they would have still been
excluded under the current statutory provisions.
The process of
separating those from the genome, however, are not covered by the ay of the
exceptions outlined in s. 1 (2) PA.
In the light
of the above, then, it would seem that companies would struggle to register a
human gene (or the process for separating and cloning one) as a valid patent
under the current UK legislation.
It remains to be
seen, however, whether the US Supreme Court will also decide, in June, that
genes should not have been patentable under US law in the first place.
Finally, would preventing
companies from patenting genes stifle investment and was Justice Kennedy not right in saying:
No comments:
Post a Comment